The effect of regulatory T-cell depletion on the spectrum of organ-specific autoimmune diseases in nonobese diabetic mice at different ages

References

• Anderson MS, Bluestone JA. The NOD mouse: A model of immune dysregulation. Annu Rev Immunol. 2005; 23:447–485.
   PubMed Web of Science ®Google Scholar
• Bach JF, Chatenoud L. Tolerance to islet autoantigens in type 1 diabetes. Annu Rev Immunol. 2001; 19:131–161.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004; 22:531–562.
   PubMed Web of Science ®Google Scholar
• Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003; 299:1057–1061.
   PubMed Web of Science ®Google Scholar
• Apostolou I, von Boehmer H. In vivo instruction of suppressor commitment in naive T cells. J Exp Med. 2004; 199:1401–1408.
   PubMed Web of Science ®Google Scholar
• Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzwei MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol. 2005; 6:1219–1227.
   PubMed Web of Science ®Google Scholar
• Haribhai D, Lin W, Edwards B, Ziegelbauer J, Salzman NH, Carlson MR, Li SH, Simpson PM, Chatila TA, Williams CBA. central role for induced regulatory T cells in tolerance induction in experimental colitis. J Immunol. 2009; 182:3461–3468.
   Google Scholar
• Curotto de Lafaille MA, Lino AC, Kutchukhidze N, Lafaille JJ. CD25− T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion. J Immunol. 2004; 173:7259–7268.
   PubMed Web of Science ®Google Scholar
• Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM. Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med. 2003; 198:1875–1886.
   PubMed Web of Science ®Google Scholar
• Zheng SG, Wang J, Wang P, Gray JD. IL-2 Is Essential for TGF-β to convert naive CD4+CD25− cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol. 2007; 178:2018–2027.
   PubMed Web of Science ®Google Scholar
• Waid DM, Vaitaitis GM, Pennock NDJr, Wagner DH. Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes. J Leukoc Biol. 2008; 84:431–439.
   PubMed Web of Science ®Google Scholar
• Wu AJ, Hong H, Munson SH, McDevitt HO. Tumor necrosis factor-α regulation of CD4+C25+ T cell levels in NOD mice. Proc Natl Acad Sci USA. 2002; 99:12287–12292.
   PubMed Web of Science ®Google Scholar
• Berzins SP, Venanzi ES, Benoist C, Mathis D. T-cell compartments of prediabetic NOD mice. Diabetes. 2003; 52:327–334.
   PubMed Web of Science ®Google Scholar
• Mellanby RJ, Thomas D, Phillips JM, Cooke A. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells. Immunology. 2007; 121:15–28.
   PubMed Web of Science ®Google Scholar
• Pop SM, Carmen PW, Donna AC, Stephen HC, Roland T. Single cell analysis shows decreasing FoxP3 and TGFβ1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes. J Exp Med. 2005; 201:1333–1346.
   PubMed Web of Science ®Google Scholar
• Gregori S, Nadia G, Simona S, Luciano A. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J Immunol. 2003; 171:4040–4047.
   PubMed Web of Science ®Google Scholar
• D'Alise AM, Auyeung V, Feuerer M, Nishio J, Fontenot J, Benoist C, Mathis D. The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proc Natl Acad Sci USA. 2008; 105:19857–19862.
   PubMedGoogle Scholar
• Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D, Ziegle SF, Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. 2001; 27:68–73.
   PubMed Web of Science ®Google Scholar
• Schorle H, Holtschke T, Hünig T, Schimpl A, Horak I. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature. 1991; 352:621–624.
   PubMed Web of Science ®Google Scholar
• Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, Sharpe A, Bluestone JA. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Proc Natl Acad Sci USA. 2000; 12:431–440.
   Google Scholar
• Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995; 155:1151–1164.
   PubMed Web of Science ®Google Scholar
• Setoguchi R, Hori S, Takahashi T, Sakaguchi S. Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med. 2005; 201:723–735.
   PubMed Web of Science ®Google Scholar
• Chen Z, Benoist C, Mathis D. How defects in central tolerance impinge on a deficiency in regulatory T cells. Proc Natl Acad Sci USA. 2005; 102:14735–14740.
   Google Scholar
• Fukushima K, Kobayashi M, Nagayama Y, Satoh T, Nakahara M, Kawasaki E, Yamasaki H, Ueha S, Matsushima K, Liu E, Eisenbarth GS, Eguchi K, Abiru N. Combined activation of innate and adaptive immunity with polyinosinic-polycytidylic acid and insulin B:9-23 self-peptide in the genetically susceptible NOD mouse: Differential effects on insulitis and diabetes progression. Biochem Biophys Res Commun. 2008; 367:719–724.
   Google Scholar
• Kobayashi M, Abiru N, Arakawa T, Fukushima K, Zhou H, Kawasaki E, Yamasaki H, Liu E, Miao D, Wong FS, Eisenbarth GS, Eguchi K. Altered B:9-23 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetes. J Immunol. 2007; 179:2082–2088.
   PubMedGoogle Scholar
• Nakahara M, Nagayama Y, Sogawa R, Saitoh O, Tone S, Abiru N. Expression of immuno-regulatory molecules on the thyrocytes protects NOD-H2h4 mice from developing autoimmune thyroiditis. Endocrinology. 2009; 150:1545–1551.
   PubMedGoogle Scholar
• Ansari MA, Dhar M, Spieker S, Bakht N, Rahman AM, Moore WV, Jacobson JD. Modulation of diabetes with gonadotropin-releasing hormone antagonists in the nonobese mouse model of autoimmune diabetes. Endocrinology. 2004; 145:337–342.
   PubMed Web of Science ®Google Scholar
• Bach JF. Insulin-dependent diabetes mellitus as an autoimmune disease. Endor Rev. 1994; 15:516–535.
   PubMed Web of Science ®Google Scholar
• McHugh RS, Shevach EM. Depletion of CD4+CD25+ Regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J Immunol. 2002; 168:5979–5983.
   PubMed Web of Science ®Google Scholar
• Alyanakian MA, You S, Damotte D, Gouarin C, Esling A, Garcia C, Havouis S, Chatenoud L, Bach JF. Diversity of regulatory CD4+ T cells controlling distinct organ-specific autoimmune diseases. Proc Natl Acad Sci USA. 2003; 100:15806–15811.
   PubMed Web of Science ®Google Scholar
• Abiru N, Yu L, Miao D, Maniatis AK, Liu E, Moriyama H, Eisenbarth GS. Transient insulin autoantibody expression independent of development of diabetes: Comparison of NOD and NOR strains. J Autoimmun. 2001; 17:1–6.
   Google Scholar